BioWorld MedTech

Aug. 30, 2013

View Archived Issues

Report from Europe: St. Jude gets CE mark for new renal denervation system

Lombard seeks stronger U.S. presence in AAA repair market

Holiday notice

Washington roundup: FDA; device reprocessor used industrial degreaser on Neptune

Deals roundup: Kindred to acquire home care Cleveland physician practice

Agreements/contracts: Bosch, Remedy enhance teleheath patient engagement

HIT roundup: McKesson releases new version of VITAL platform for payers

Financings roundup: Audax Health Solutions raises $20 million in Series B round

Product Briefs

People in Places

MDD s Diagnostic Extra

Contradicting reports on investigtiation: China authorities say no pricing investigation underway

Contradicting a series of reports earlier in the week, authorities in China say they are not currently investigating pricing issues in the medical device industry. Read More

The MDD Interview: Size, geographic fit are key in hospitals consolidation

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Approved label with medical icons, professional

FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave

BioWorld MedTech

Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...

ADPD 2025: Novel treatment modalities in neurodegenerative disorders

BioWorld Science

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...